ARIX — Arix Bioscience Share News
0.000.00%
- £183.80m
- £82.85m
- £0.11m
- 29
- 34
- 90
- 48
REG-Arix Bioscience PLC Unaudited NAV for October 2023
AnnouncementREG-Arix Bioscience PLC PDMR Notification & Director Shareholding
AnnouncementREG-Arix Bioscience PLC PDMR Notification & Director Shareholding
AnnouncementREG-Arix Bioscience PLC Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
AnnouncementREG - RTW Biotech Opp. Arix Bioscience Plc - RTW Biotech to acquire Arix Bioscience's assets
AnnouncementREG-Arix Bioscience PLC Portfolio company Harpoon Therapeutics announces up to $150 million private placement
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for September 2023
AnnouncementREG-Arix Bioscience PLC Board Change
AnnouncementREG-Arix Bioscience PLC Interim Results for the Six Months Ended 30 June 2023
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for August 2023
AnnouncementREG-Arix Bioscience PLC Notice of Results and Investor Presentation
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for July 2023
AnnouncementREG-Arix Bioscience PLC Holding(s) in Company
AnnouncementREG-Arix Bioscience PLC Arix Announces Strategic Review
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for June 2023
AnnouncementREG-Arix Bioscience PLC Portfolio company Disc Medicine raises $157.8 million in public offering
AnnouncementREG-Arix Bioscience PLC Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for May 2023
AnnouncementREG - Arix Bioscience Plc - Director/PDMR Shareholding
Announcement